The Clean-Label-Friendly Solution: Stabilizing Milk-Based Cocoa Beverages with Citrus Fiber
Abstract
The increasing demand for clean label products has driven the development of natural and sustainable stabilizers in the food industry. This study investigates the potential of citrus fiber as a clean-label-friendly ingredient to improve the stability of cocoa-based dairy beverages. A Central Composite Rotatable Design (CCRD) was employed to evaluate the effects of homogenization pressure (100-300 bar) and citrus fiber concentration (0.10-0.40%) on the water-holding capacity (WHC), sedimentation, creaming index, pH, viscosity, and torque. Analytical methods including zeta potential, FTIR, particle size distribution, microscopy, and SEM-EDS were utilized to assess the structural properties and stability of the formulations. The results demonstrated significant improvements under optimal conditions that citrus fiber significantly enhanced WHC (95.95%), minimized sedimentation (0%) with creaming index (0%), and improved viscosity (197.22 mPa·s), contributing to a homogeneous dispersion of cocoa particles. Homogenization pressure and citrus fiber concentration exhibited synergistic effects, optimizing the physical stability of the beverage. Zeta potential (-27.90 mV) and particle size (630.53 nm) distribution analysis indicated improved electrostatic stability and reduced particle aggregation, while FTIR revealed interactions between citrus fibers and cocoa components. Microscopic analysis, molecular docking, and SEM-EDS further confirmed the structural integration of citrus…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.